| 1 |
Liu J, Duan S, Wang Y, Peng H, Kong Y, Yao S. Efficacy and safety of underwater endoscopic mucosal resection for ≤20 mm superficial non-ampullary duodenal epithelial tumors: Systematic review and meta-analysis. Front Med (Lausanne) 2022;9:1077806. [PMID: 36687419 DOI: 10.3389/fmed.2022.1077806] [Reference Citation Analysis]
|
| 2 |
Rykina-Tameeva N, Samra JS, Sahni S, Mittal A. Drain fluid biomarkers for prediction and diagnosis of clinically relevant postoperative pancreatic fistula: A narrative review. World J Gastrointest Surg 2022; 14(10): 1089-1106 [DOI: 10.4240/wjgs.v14.i10.1089] [Reference Citation Analysis]
|
| 3 |
Chen PC, Lu YR, Kang YN, Chang CC. The Accuracy of Artificial Intelligence in the Endoscopic Diagnosis of Early Gastric Cancer: Pooled Analysis Study. J Med Internet Res 2022;24:e27694. [PMID: 35576561 DOI: 10.2196/27694] [Reference Citation Analysis]
|
| 4 |
Nabi Z, Ramchandani M, Basha J, Goud R, Darisetty S, Reddy DN. POEM Is a Durable Treatment in Children and Adolescents With Achalasia Cardia. Front Pediatr 2022;10:812201. [DOI: 10.3389/fped.2022.812201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Hillhouse E, Mathurin K, Bibeau J, Parison D, Rahal Y, Lachaine J, Beauchemin C. The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review. Adv Ther 2022;39:455-87. [PMID: 34780028 DOI: 10.1007/s12325-021-01951-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 6 |
Boros E, Sipos Z, Hegyi P, Teutsch B, Frim L, Váncsa S, Kiss S, Dembrovszky F, Oštarijaš E, Shawyer A, Erőss B. Prophylactic transcatheter arterial embolization reduces rebleeding in non-variceal upper gastrointestinal bleeding: A meta-analysis. World J Gastroenterol 2021; 27(40): 6985-6999 [PMID: 34790019 DOI: 10.3748/wjg.v27.i40.6985] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Pitchumoni CS, Goldstein DR, Vuittonet CL. Gas, Belching, Bloating, and Flatulence: Pathogenesis, Evaluation, and Management. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_44] [Reference Citation Analysis]
|
| 8 |
Chen X, Xu MT, Wen JB. Meta-analysis of vonoprazan and proton pump inhibitors in preventing delayed bleeding and facilitating ulcer healing after gastric endoscopic submucosal dissection. Shijie Huaren Xiaohua Zazhi 2020; 28(24): 1249-1260 [DOI: 10.11569/wcjd.v28.i24.1249] [Reference Citation Analysis]
|
| 9 |
Pitchumoni CS, Goldstein DR, Vuittonet CL. Gas, Belching, Bloating, and Flatulence: Pathogenesis, Evaluation, and Management. Geriatric Gastroenterology 2020. [DOI: 10.1007/978-3-319-90761-1_44-1] [Reference Citation Analysis]
|
| 10 |
Adalimumab. Reactions Weekly 2019;1739:16-16. [DOI: 10.1007/s40278-019-57656-8] [Reference Citation Analysis]
|
| 11 |
Infliximab. Reactions Weekly 2019;1739:153-153. [DOI: 10.1007/s40278-019-57793-2] [Reference Citation Analysis]
|
| 12 |
Azathioprine. Reactions Weekly 2019;1739:55-55. [DOI: 10.1007/s40278-019-57695-4] [Reference Citation Analysis]
|
| 13 |
Propofol/remifentanil. Reactions Weekly 2019;1739:215-215. [DOI: 10.1007/s40278-019-57855-4] [Reference Citation Analysis]
|
| 14 |
Proton pump inhibitor/tripotassium-dicitrato-bismuthate/tetracycline/metronidazole. Reactions Weekly 2019;1739:217-217. [DOI: 10.1007/s40278-019-57857-4] [Reference Citation Analysis]
|
| 15 |
Infliximab. Reactions Weekly 2019;1739:152-152. [DOI: 10.1007/s40278-019-57792-2] [Reference Citation Analysis]
|
| 16 |
Vedolizumab. Reactions Weekly 2019;1739:246-246. [DOI: 10.1007/s40278-019-57886-1] [Reference Citation Analysis]
|
| 17 |
Yttrium-90. Reactions Weekly 2019;1739:253-253. [DOI: 10.1007/s40278-019-57893-0] [Reference Citation Analysis]
|
| 18 |
Mesalazine. Reactions Weekly 2019;1739:174-174. [DOI: 10.1007/s40278-019-57814-8] [Reference Citation Analysis]
|
| 19 |
Heparin. Reactions Weekly 2019;1739:137-137. [DOI: 10.1007/s40278-019-57777-4] [Reference Citation Analysis]
|
| 20 |
Vedolizumab. Reactions Weekly 2019;1739:245-245. [DOI: 10.1007/s40278-019-57885-1] [Reference Citation Analysis]
|
